• A strategic collaboration to speed up the development of allogeneic cell therapies

    11 days ago - By News Medical

    The University of Texas MD Anderson Cancer Center and Allogene Therapeutics, Inc. today announced a strategic five-year collaboration agreement for the preclinical and clinical investigation of AlloCAR T candidates across Allogene's broad portfolio of hematologic and solid tumors.
    Read more ...